Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.

Hims and Hers announced this morning that it will begin offering compounded semaglutide (generic Ozempic or Wegovy) for $199 ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as potential vision loss.

Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...

You'll want to opt for grass-fed or organic, since processed meats, like bacon, aren't allowed. But if organic isn’t in your budget, choose leaner cuts of conventionally raised meat, suggests ...

Under the deal, cash-paying patients can access a month's supply of Wegovy through the Danish drugmaker's Novocare pharmacy ...

Wegovy, a weight-loss injection containing semaglutide, has arrived in India, offering a new approach to combatting obesity and related metabolic issues. Experts emphasize it's not a quick fix but ...

The U.S. Food and Drug Administration removed semaglutide, the active ingredient in Wegovy, from its shortage list earlier this year and did the same for tirzepatide, the active ingredient in ...

COPENHAGEN - Danish drugmaker Novo Nordisk will launch its weight-loss drug Wegovy in India without any supply constraints, a company spokesperson said on Tuesday. "We are committed to addressing the ...

Novo Nordisk has launched its anti-obesity drug Wegovy in India, aimed at long-term weight management and reducing cardiovascular risk. The company targets large-scale distribution, aiming to become a ...